WO2026069010 - COMPOSITIONS AND SYSTEMS FOR TREATING CANCER USING TUMOR TREATING FIELDS (TTFIELDS) AND ACE INHIBITORS
National phase entry is expected:
Publication Number
WO/2026/069010
Publication Date
02.04.2026
International Application No.
PCT/IB2025/052402
International Filing Date
05.03.2025
Title **
[English]
COMPOSITIONS AND SYSTEMS FOR TREATING CANCER USING TUMOR TREATING FIELDS (TTFIELDS) AND ACE INHIBITORS
[French]
COMPOSITIONS ET SYSTÈMES POUR LE TRAITEMENT DU CANCER À L'AIDE DE CHAMPS DE TRAITEMENT DE TUMEUR (TTFIELDS) ET D'INHIBITEURS D'ACE
Applicants **
NOVOCURE GMBH
Inventors
LAVY-SHAHAF, Gitit
VOLOSHIN-SELA, Tali
AVIGDOR, Lilach
Priority Data
63/699,237
26.09.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2144 | |
| EPO | Filing, Examination, Granting | 9037 | |
| Japan | Filing, Examination, Granting | 2203 | |
| South Korea | Filing, Examination, Granting | 2119 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
22,043
Contact Us
Abstract[English]
Compositions, kits, combinatorial treatments, systems, and methods for reducing viability of cancer cells and treating cancer, as well as reducing a volume of a tumor and/or preventing an increase in volume of a tumor present in a body of a living subject, along with increasing median survival of a subject with cancer, are disclosed. The systems and methods involve application of an alternating electric field in combination with administration of at least one composition comprising at least one angiotensin-converting enzyme (ACE) inhibitor.[French]
L'invention concerne des compositions, des kits, des traitements combinés, des systèmes et des procédés de réduction de la viabilité de cellules cancéreuses et de traitement du cancer, ainsi que de réduction du volume d'une tumeur et/ou de prévention de l'augmentation du volume d'une tumeur présente dans un corps d'un sujet vivant, conjointement avec l'augmentation de la survie médiane d'un sujet atteint d'un cancer. Les systèmes et les procédés impliquent l'application d'un champ électrique alternatif en combinaison avec l'administration d'au moins une composition comprenant au moins un inhibiteur de l'enzyme de conversion de l'angiotensine (ACE).